BR

Biswabhusan Rout

Active Director Director DIN 10573081
DIN 10573081 First appointment Apr 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Biswabhusan Rout

Data last updated:

Biswabhusan Rout is a Director at Bjb Life Sciences Private Limited (since 2024) and Managing Director at Jb Stoma Care Private Limited (since 2024).

DIN 10573081
Primary Designation Director
First Appointment 01 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bjb Life Sciences Private Limited U46497DL2024PTC439350
Director28 Nov 20242024Active
Jb Stoma Care Private Limited U46497OD2024PTC045431
Managing Director01 Apr 20242024Active

Board colleagues of Biswabhusan Rout

Directorship timeline

Open interactive timeline →
Bjb Life Sciences Private Limited
Jb Stoma Care Private Limited
Premium access

Shareholding and investment profile for Biswabhusan Rout

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biswabhusan Rout

Biswabhusan Rout currently holds 2 directorships: Bjb Life Sciences Private Limited (Director, since 28 Nov 2024); Jb Stoma Care Private Limited (Managing Director, since 01 Apr 2024).

Biswabhusan Rout was first appointed on 01 Apr 2024 as Managing Director at Jb Stoma Care Private Limited.

The current boards of Biswabhusan Rout's companies include Puspashree Rout (Bjb Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available